Indivior stock carries a USD 8.13 special dividend
Published on 09/25/2026 at 12:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Indivior stock carried a USD 8.13 special dividend catalyst after the company announced the payment on September 17, 2026, subject to completion of its Supernus Pharmaceuticals merger. Shares traded at USD 36 on Nasdaq on September 24, 2026, up USD 0.09 or 0.25 percent from the prior close.
Dividend depends on merger closing
According to Business Insider on September 17, 2026, the USD 8.13 payment is scheduled for holders of record on October 30, 2026, with payment expected on November 6, 2026, if the merger closes.
The proposed combination with Supernus Pharmaceuticals is expected to close on November 2, 2026, according to the same company announcement carried by StockTitan. The dividend therefore links a defined shareholder payment to a transaction condition rather than to ordinary quarterly distribution policy.
Q2 revenue beats consensus
For the quarter ended June 30, 2026, Indivior reported total net revenue of USD 343 million, up 14 percent year over year, while SUBLOCADE revenue reached USD 253 million, up 21 percent. StockTitan also reported GAAP net income of USD 122 million and adjusted EBITDA of USD 186 million for the period.
The revenue figure exceeded the USD 308 million consensus cited by AInvest on September 2, 2026, by USD 35 million, or 11.4 percent. Adjusted earnings per share came to USD 1.15 versus a USD 0.97 consensus, a 125.5 percent year-over-year increase.
Analyst target stays above price
MarketBeat reported on September 20, 2026, that six analysts rated Indivior Buy and one rated it Hold, producing a Moderate Buy consensus and a USD 45.17 average 12-month price target. That target lies 25.5 percent above the September 24, 2026 Nasdaq price of USD 36.
Market data place the stock between a 52-week low of USD 22.56 and a high of USD 42.81 as of September 24, 2026. The USD 4.49 billion market capitalization and 1,203,255-share volume give the dividend and merger timetable a market context without changing the transaction condition.
Stock remains below yearly high
Indivior traded at USD 36 on Nasdaq on September 24, 2026, with a 52-week range of USD 22.56 to USD 42.81 and a daily change of 0.25 percent. The next material dates are October 30, 2026 for the shareholder record date and November 6, 2026 for the expected dividend payment.
Indivior stock facts
- Company: Indivior Pharmaceuticals, Inc.
- Ticker: INDV
- Trading venue: Nasdaq
- Price (as of September 24, 2026): USD 36
- Market capitalization: USD 4,491,720,000 (as of September 24, 2026)
- 52-week range: USD 22.56-42.81 (as of September 24, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
